March 21st 2025
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Satellite Symposia at the 2025 Oncology Nursing Society Congress
April 11-12, 2025
Register Now!
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Obesity Linked To Failed Induction, Increased Neonatal Morbidity
August 7th 2011The increasing epidemic of obesity affects all areas of obstetrics. Obesity is associated with medical, surgical, and obstetrical complications and higher rates of induction dysfunctional labor patterns. Since one-third of all reproductive-aged women are obese and almost 10% are extremely obese, this represents a significant problem for obstetricians. Thus, researchers from the division of maternal fetal medicine in the department of obstetrics and gynecology at University of Cincinnati College of Medicine in Ohio conducted a study to better understand the association between failed induction and obesity as well as to determine if the link is correlated with increasing class of obesity.
Read More
Clinical Guidelines for Evaluation and Management of Amenorrhea
August 5th 2011Definitions Primary amenorrheaFailure of menarche to occur when expected in relation to the onset of pubertal development. • No menarche by age 16 years with signs of pubertal development. • No onset of pubertal development by age 14 years. Secondary amenorrhea • Absence of menstruation for 3 or more months in a perviously mentruating women of reproductive age.
Read More
PROCLACTIN • Is a polypeptide hormone containing 198 amino acids and having a molecular weight of 22,000 daltons. • It curculates in different molecular sizes- a (small) form (mol wt 22,000), and a (big) form (mol wt 50,000), and an even larger (big-big) form (mol wt > 100,000). • The small form is biologically active, and about 80% of the hormone secreted is in this
Read More
New role for tamoxifen as fertility drug for breast cancer patients?
August 3rd 2011In a study published today in Europe's leading reproductive medicine journal Human Reproduction1, researchers from New York's Cornell University report the first IVF pregnancy to result from the use of tamoxifen as an ovarian stimulant.
Read More
Transdermal Contraceptive System: Clinical Management
August 3rd 2011Disclosure Declaration •Grant Support –National Institutes of Health, Ortho-McNeil Pharmaceutical, Inc, Pharmacia Corp., Berlex Laboratories, Proctor and Gamble •Honoraria and consultation fees –Ortho-McNeil Pharmaceutical, Inc., Berlex Laboratories, Pharmacia Corp., TAP Pharmaceuticals, Eli Lilly and Co. •Participation in company sponsored speakers’ bureau –Ortho-McNeil Pharmaceutical, Inc., Berlex Laboratories, Pharmacia Corp., Merck Pharmaceuticals.
Read More
Intra Uterine Contraceptive Devices (I.U.C.D.)
August 3rd 2011Presented by Dr. Narayan M. Patel M.D., D.G.O. FICSEmeritus Professor Muni. Medical collegePostal address-Mahalaxmi Institute of Medical Teaching,3, Shantiniketan park, Naranpura,Nr. Sardar Patel Colony,AHMEDABAD- 380 014 (Gujarat) INDIA E mail:- nmpatel1932@wilnetonline.net
Read More
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System Ronald T. Burkman, MD Baystate Medical Center Tufts University School of Medicine
Read More
Medical Management of Endometriosis, Uterine Fibroids and Dysfunctional Uterine Bleeding
August 2nd 2011Hysterectomy is one of the most common abdominal surgical procedures performed in women today with 600,000 hysterectomies in the USA annually, one in three women undergoing hysterectomy, and 6–20% in European countries.
Read More
Urinary Incontinence and how it fits in with an OB/GYN Practice
August 2nd 2011Roberta Speyer: “This is Roberta Speyer and I’m reporting for OBGYN.net. I have the pleasure of talking to Dr. Fleischman who is an Assistant Clinical Professor at Yale University and in private practice with Gynecology & Infertility, PC. Today we are going to talk about urinary incontinence and how OBGYN physicians can fit this into their practice. As a practicing OBGYN yourself, this is something you have a great degree of specialization in. Tell us a little about your practice Dr. Fleischman.”
Read More
Perimenopausal and Postmenopausal Health
August 2nd 2011The average age of natural menopause in Western societies is estimated to be 51 years; women in Canada can therefore expect to live, on average, a third of their lives in post-menopausal years. During these years women are at increased risk of chronic diseases such as osteoporosis and cardiovascular disease.
Read More
Poll: Will You Recommend Triptorelin to Reproductive-Age Patients With Breast Cancer?
August 2nd 2011Researchers from Italy have found that premenopausal breast cancer patients treated with triptorelin and chemotherapy were less likely to experience early menopause and were more likely to resume menses than patients who received chemotherapy alone.
Read More
Triptorelin Reduces the Risk of Chemotherapy-Induced Early Menopause
August 2nd 2011The use of chemotherapy for the treatment of breast cancer can result in transient or permanent amenorrhea, and research indicates that each month of chemotherapy translates into 1.5 year of lost reproductive life. This is especially significant for women younger than 40 years, which accounts for 6% of the population diagnosed with breast cancer.
Read More
This is the exercise which, when done faithfully and correctly, can help decrease the urgency a patient may have and help with both urge incontinence and stress incontinence. The pelvic floor muscle is like a hammock that stretches from the pubic bone in the front to the tailbone in the back.
Read More
Hilights From Fertility And Sterility
July 26th 2011In an extensive, multi-center clinical treatment trial, Canadian researchers evaluated the outcomes of 538 cases of uterine artery embolization for fibroids. Between 20% and 50% of women develop uterine fibroids, benign tumors in the muscular tissue of the uterus that can seriously impact their health and well-being.
Read More
Ultrasound Is the Only Monitoring Modality Necessary For Ovulation Induction
July 21st 2011Ovulation induction is based on the administration of gonadotropins in order to enhance fertility. Daily administration of the drug causes a supra-physiological increase in serum FSH leading to the recruitment of a larger cohort of follicles, further causes their growth and development, and finally, triggering ovulation of usually more than one follicle.
Read More
Smoking and reproduction: The oviduct as a target of cigarette smoke
July 20th 2011The oviduct is an exquisitely designed organ that functions in picking-up ovulated oocytes, transporting gametes in opposite directions to the site of fertilization, providing a suitable environment for fertilization and early development, and transporting preimplantation embryos to the uterus.
Read More
Cystic Fibrosis and Fertility Treatment
July 19th 2011Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children, according to new research presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam today (Tuesday).
Read More
Reduced Ovarian Reserve and Down's Syndrome
July 19th 2011Women who have a diminished number of eggs in their ovaries, either because they are older or for some other reason such as ovarian surgery, may be more at risk of a trisomic pregnancy than women with an ovarian reserve within the normal, fertile range.
Read More
New Test for Both Genetic and Chromosomal Abnormalities in Embryos
July 19th 2011One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis.
Read More
Reduce Multiple Pregnancies in PGD Cycles without Adversely Affecting Pregnancy Rates
July 19th 2011Transferring just one embryo at a time to a woman’s womb after embryos have undergone preimplantation genetic diagnosis (PGD) and freezing at the blastocyst stage has become a real option after researchers achieved pregnancy rates that were as good as those for blastocysts that had not had a cell removed for PGD before freezing.
Read More